← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
CRH grew revenue +5.3%, net income +7.5%, and FCF +20.8%, while debt rose +26.6%.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +5.3% to $37.45BOK
- Profitability — Net income +7.5% to $3.75BOK
- Cash quality — FCF +20.8% to $2.91BOK
- Margins — Gross +42 bps; operating margin +68 bpsOK
- Balance sheet — Debt +26.6% to $17.53BWatch
- Insiders — 2 buys / 2 sellsNote
Business
CRH is a global building-materials and construction-solutions company serving infrastructure, residential, non-residential, transportation, water, energy, telecom, reindustrialization, and outdoor-living markets across North America, Europe, and Australia.
Where the revenue comes from
Fiscal 2025, as CRH PUBLIC LTD CO reports it. History and quarterly detail are in the app.
- Americas Materials Solutions$17.0B
- International Solutions$13.3B
- Americas Building Solutions$7.1B
Leadership changes
From CRH PUBLIC LTD CO's own filings, the day they're filed.
- W. Anthony · Director · appointmenteff. 2026-07-01
- Nancy Buese · Chief Financial Officer · departureeff. 2026-05-11
- Patrick Decker · Director · appointmenteff. 2025-10-01
Latest filings
- 10-Q · Quarterly report2026-07-30
- 8-K · Company announcement2026-07-30
- 8-K · Company announcement2026-07-17
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-06-16
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CRH PUBLIC LTD CO, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.